Search the Site
Follow TheCancerLetter on Twitter
join our mailing list

Enter your name and email address to receive an update when we post new content.

IP Login
The Cancer Letter Inc.
PO Box 9905
Washington
DC 20016
Tel: 202-362-1809
Fax: 202-379-1787
Twitter:
@TheCancerLetter
Facebook:
/TheCancerLetter
publication date: Apr 29, 2011
Special Free Issue - Open to the Public

  • Reviewers find I-ELCAP is a trial that never ends, with 90 percent of consent forms unobtainable
  • Excerpts from a confidential report detailing the I-ELCAP study's design flaws and lack of consent
  • Henschke responds to questions from The New York Times
  • Raymond Weiss reviews confidential report on I-ELCAP

Copyright (c) 2014 The Cancer Letter Inc.
Letter